MarketScreener Editorial Features Neoprobe Corporation Nyse
Equities
NEOP
US6405181065
End-of-day quote
Other stock markets
|
||
- USD | - |
Jun. 21 | Navidea Biopharmaceuticals, Inc. Announces Board Resignations | CI |
2023 | Navidea Biopharmaceuticals, Inc. announced that it has received $0.75 million in funding | CI |
- Stock Market
- Equities
- NAVB Stock
- NEOP Stock
- News Neoprobe Corporation
- MarketScreener Editorial Features